Antiproliferative Activity of Lignans from Olea ferruginea: In Vitro Evidence Supported by Docking Studies.

BACKGROUND The aim of the current study was to investigate the anticancer potential of bioactive compounds isolated from the leaves of Olea ferruginea (O. ferruginea). Lignans from O. ferruginea were previously described to possess antibacterial, antileishmanial, and antioxidant properties. Nevertheless, the antiproliferative activity of cycloolivil (1), ferruginan (2), and ferruginan A (3) have not been investigated in depth. METHODS The compounds were isolated from the ethyl acetate fraction of the leaves extract of O. ferruginea. The isolated molecules were evaluated for their anticancer activity against U-87 MG malignant glioma cells. In parallel, molecular docking studies were also performed to investigate the interaction of the compounds with a duplex DNA sequence and epidermal growth factor receptor (EGFR). RESULTS In vitro tests showed that all three compounds inhibit U-87 MG malignant glioma cell proliferation dose-dependently in the µM range, and ferruginan A (3) was highlighted as the most promising compound of the set. Molecular docking studies showed that the compounds could interfere with double stranded DNA possessing a cisplatin 1,2-d(GpG) intrastrand cross-link and EGFR. CONCLUSIONS Overall, the findings suggest that the tested compounds from O. ferruginea may represent a starting point for the identification of novel tools to inhibit glioma cell proliferation.

[1]  A. Javed,et al.  Green synthesised AuNps using Ajuga Bracteosa extract and AuNps-Free supernatant exhibited equivalent antibacterial and anticancerous efficacies , 2023, PloS one.

[2]  A. Rauf,et al.  Anti-Inflammatory and Anti-Diabetic Activity of Ferruginan, a Natural Compound from Olea ferruginea , 2023, Processes.

[3]  A. Javed,et al.  Glioblastoma Multiforme: Probing Solutions to Systemic Toxicity towards High-Dose Chemotherapy and Inflammatory Influence in Resistance against Temozolomide , 2023, Pharmaceutics.

[4]  Zev A. Binder,et al.  EGFR, the Lazarus target for precision oncology in glioblastoma. , 2022, Neuro-oncology.

[5]  Y. Mabkhot,et al.  Antioxidant and Cytotoxic Activity of a New Ferruginan A from Olea ferruginea: In Vitro and In Silico Studies , 2022, Oxidative medicine and cellular longevity.

[6]  Fang You,et al.  Drug repositioning: Using psychotropic drugs for the treatment of glioma. , 2021, Cancer letters.

[7]  U. Rashid,et al.  Tailoring the substitution pattern of Pyrrolidine-2,5-dione for discovery of new structural template for dual COX/LOX inhibition. , 2021, Bioorganic chemistry.

[8]  A. Mehmood,et al.  Investigation of Olea ferruginea Roylebark extracts for potential in vitroantidiabetic and anticancer effects , 2021, Turkish journal of chemistry.

[9]  R. Sharma,et al.  Antioxidant properties, phenolics and flavonoids content of some economically important plants from North-west Indian Himalaya , 2021, Natural product research.

[10]  A. Rauf,et al.  Potent leishmanicidal and antibacterial metabolites from Olea ferruginea , 2019, Journal of Asian natural products research.

[11]  I. Majsterek,et al.  Comparison of the effect of three different topoisomerase II inhibitors combined with cisplatin in human glioblastoma cells sensitized with double strand break repair inhibitors , 2019, Molecular Biology Reports.

[12]  U. Farooq,et al.  Isolation of dihydrobenzofuran derivatives from ethnomedicinal species Polygonum barbatum as anticancer compounds , 2019, Biological Research.

[13]  R. Abbasi,et al.  Natural products as reservoirs of novel therapeutic agents , 2018, EXCLI journal.

[14]  In-Jung Lee,et al.  In Vitro Antidiabetic Effects and Antioxidant Potential of Cassia nemophila Pods , 2018, BioMed research international.

[15]  E. Mukwevho,et al.  Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases , 2017, Molecules.

[16]  Zia-ur-Rehman,et al.  Synthesis, characterization, cytotoxicity and computational studies of new phosphine‐ and carbodithioate‐based palladium(II) complexes , 2017 .

[17]  Á. Carracedo,et al.  Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines , 2017, Cancer Cell International.

[18]  M. Crisma,et al.  New naphthoquinone derivatives against glioma cells. , 2015, European journal of medicinal chemistry.

[19]  R. Quinn,et al.  Guiding principles for natural product drug discovery. , 2012, Future medicinal chemistry.

[20]  W. Cavenee,et al.  Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance. , 2012, Current cancer drug targets.

[21]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[22]  D. Abebe,et al.  Screening of some medicinal plants of Ethiopia for their anti-microbial properties and chemical profiles. , 2005, Journal of ethnopharmacology.

[23]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[24]  Marzieh Ebrahimi,et al.  Glioblastoma cancer stem cell biology: Potential theranostic targets. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[25]  Muhammad Ali Hashmi,et al.  Anticancer and Alkaline Phosphatase Inhibitory Effects of Compounds Isolated from the Leaves of Olea ferruginea Royle , 2014 .

[26]  L. Nahar,et al.  An introduction to natural products isolation. , 2012, Methods in molecular biology.